Literature DB >> 2038058

Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution.

M A Saper1, P J Bjorkman, D C Wiley.   

Abstract

The three-dimensional structure of the human histocompatibility antigen HLA-A2 was determined at 3.5 A resolution by a combination of isomorphous replacement and iterative real-space averaging of two crystal forms. The monoclinic crystal form has now been refined by least-squares methods to an R-factor of 0.169 for data from 6 to 2.6 A resolution. A superposition of the structurally similar domains found in the heterodimer, alpha 1 onto alpha 2 and alpha 3 onto beta 2m, as well as the latter pair onto the ancestrally related immunoglobulin constant domain, reveals that differences are mainly in the turn regions. Structural features of the alpha 1 and alpha 2 domains, such as conserved salt-bridges that contribute to stability, specific loops that form contacts with other domains, and the antigen-binding groove formed from two adjacent helical regions on top of an eight-stranded beta-sheet, are analyzed. The interfaces between the domains, especially those between beta 2m and the HLA heavy chain presumably involved in beta 2m exchange and heterodimer assembly, are described in detail. A detailed examination of the binding groove confirms that the solvent-accessible amino acid side-chains that are most polymorphic in mouse and human alleles fill up the central and widest portion of the binding groove, while conserved side-chains are clustered at the narrower ends of the groove. Six pockets or sub-sites in the antigen-binding groove, of diverse shape and composition, appear suited for binding side-chains from antigenic peptides. Three pockets contain predominantly non-polar atoms; but others, especially those at the extreme ends of the groove, have clusters of polar atoms in close proximity to the "extra" electron density in the binding site. A possible role for beta 2m in stabilizing permissible peptide complexes during folding and assembly is presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2038058     DOI: 10.1016/0022-2836(91)90567-p

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  271 in total

1.  Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two alpha beta T cell receptors.

Authors:  D Rognan; A Stryhn; L Fugger; S Lyngbaek; J Engberg; P S Andersen; S Buus
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  A relation between the principal axes of inertia and ligand binding.

Authors:  J Foote; A Raman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses.

Authors:  F Micheletti; M Bazzaro; A Canella; M Marastoni; S Traniello; R Gavioli
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

Review 4.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 5.  Immune recognition, response, and regulation: how T lymphocytes do it.

Authors:  S Joyce
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition.

Authors:  Giuliana Verdone; Alessandra Corazza; Paolo Viglino; Fabio Pettirossi; Sofia Giorgetti; Palma Mangione; Alessia Andreola; Monica Stoppini; Vittorio Bellotti; Gennaro Esposito
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

7.  Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

Authors:  Alessandro Sette; John Sidney; Brian D Livingston; John L Dzuris; Claire Crimi; Christopher M Walker; Scott Southwood; Edward J Collins; Austin L Hughes
Journal:  Immunogenetics       Date:  2003-02-14       Impact factor: 2.846

8.  A comparative molecular similarity index analysis (CoMSIA) study identifies an HLA-A2 binding supermotif.

Authors:  Irini A Doytchinova; Darren R Flower
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

Review 9.  Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

10.  Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.

Authors:  Ana Goyos; Yuko Ohta; Sergey Guselnikov; Jacques Robert
Journal:  Mol Immunol       Date:  2009-02-23       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.